NEOG logo

Neogen Corporation (NEOG)

$10.90

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on NEOG

Market cap

$2.38B

EPS

-0.26

P/E ratio

--

Price to sales

2.93

Dividend yield

--

Beta

1.862126

Price on NEOG

Previous close

$10.88

Today's open

$10.83

Day's range

$10.76 - $11.05

52 week range

$5.37 - $14.26

Profile about NEOG

CEO

Mike Nassif

Employees

2636

Headquarters

Lansing, MI

Exchange

Nasdaq Global Select

Shares outstanding

218306034

Issue type

Common Stock

NEOG industries and sectors

Healthcare

Medical Diagnostics & Screening

News on NEOG

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG

NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

news source

PRNewsWire • Nov 12, 2026

news preview

Neogen (NEOG) Up 6.7% Since Last Earnings Report: Can It Continue?

Neogen (NEOG) reported earnings 30 days ago. What's next for the stock?

news source

Zacks Investment Research • Nov 5, 2026

news preview

Neogen® To Participate in 2026 UBS Global Healthcare Conference

LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2026 UBS Global Healthcare Conference in Palm Beach Gardens, FL on Tuesday, November 10. About Neogen Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock,.

news source

Business Wire • Nov 3, 2026

news preview

NEOG vs. WFCF: Which Food Safety Stock Has Better Prospects?

Neogen beats Where Food Comes From in revenue growth and recovery potential, but higher debt and integration risks complicate the food safety stock showdown.

news source

Zacks Investment Research • Oct 20, 2026

news preview

Neogen Corporation (NEOG) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa. , Oct. 15, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G.

news source

GlobeNewsWire • Oct 15, 2026

news preview

Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) investors concerning the Company's possible violations of the federal securities laws.

news source

GlobeNewsWire • Oct 15, 2026

news preview

Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES, Oct. 14, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) on behalf of investors concerning the Company's possible violations of federal securities laws.

news source

GlobeNewsWire • Oct 14, 2026

news preview

3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds

Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.

news source

Zacks Investment Research • Oct 9, 2026

news preview

Neogen Corporation: Promising Recurring Demand With Food Safety

I believe Neogen's recurring food safety products provide a foundation for its operating recovery. However, management has to execute carefully and proceed with the Petrifilm transition, which, if successful, should improve its cash flows long-term. Also, NEOG's recent genomics sale should give it extra flexibility, but we have to wait and see until we know how much its earnings may decrease as a result.

news source

Seeking Alpha • Oct 8, 2026

news preview

Neogen Investor Day Sets Path for Growth, 30% EBITDA Margin by 2031

Neogen NASDAQ: NEOG outlined a multi-year strategy at its first Investor Day, emphasizing a shift from business stabilization toward accelerated growth, higher margins and stronger cash generation. Management said the company has delivered positive core growth for four consecutive quarters and is targeting high-single-digit to low-double-digit long-term revenue growth, adjusted gross margins in the high-50% range, adjusted EBITDA margins of approximately 30% and free-cash-flow conversion of about 80% by fiscal 2031.

news source

MarketBeat • Oct 8, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Neogen Corporation

Open an M1 investment account to buy and sell Neogen Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in NEOG on M1